Financial Times FT.com

Biogen Idec's first round bids due next week with Pfizer considered one of the front runners

By Nadia Damouni in New York and Andre Sawyer in London

Published: November 7 2007 17:13 | Last updated: November 7 2007 17:13

Email options

The information entered on this page will not be used to send unsolicited email, and will not be sold to a 3rd party.Terms of use |Privacy policy

* required fields



(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)